• SENSEX
    NIFTY 50
Market

Tuesday's top brokerage calls: Tata Motors, Glenmark Pharma, ONGC and more

Updated : February 16, 2021 08:51 AM IST

Among brokerages, UBS is 'neutral' on Tata Motors while HSBC and Morgan Stanley had 'hold' and 'underperform' calls, respectively for Glenmark Pharma post the pharma major's December quarter earnings. Here are the top brokerage calls for today:

 UBS on Tata Motors:  The brokerage maintains a 'neutral' call on the stock with a target price of Rs 360 per share. It expects JLR to be £0.5 Billion net cash by FY23.
UBS on Tata Motors: The brokerage maintains a 'neutral' call on the stock with a target price of Rs 360 per share. It expects JLR to be £0.5 Billion net cash by FY23.
 HSBC on Glenmark Pharma:  The brokerage maintains a 'hold' call on the stock with a target at Rs 550 per share. It believes successful capital raise and/or R&D asset deal by Ichnos to be key catalysts.
HSBC on Glenmark Pharma: The brokerage maintains a 'hold' call on the stock with a target at Rs 550 per share. It believes successful capital raise and/or R&D asset deal by Ichnos to be key catalysts.
 Morgan Stanley on Glenmark:  The brokerage has an 'underperform' call on the stock with a target at Rs 424 per share. It added that core business should grow at mid-teens and margin should be stable.
Morgan Stanley on Glenmark: The brokerage has an 'underperform' call on the stock with a target at Rs 424 per share. It added that core business should grow at mid-teens and margin should be stable.
 Credit Suisse on NMDC:  The brokerage initiated coverage on the stock with an 'outperform' call and a target at Rs 162 per share. It added that the company will maintain elevated EBITDA in the coming years.
Credit Suisse on NMDC: The brokerage initiated coverage on the stock with an 'outperform' call and a target at Rs 162 per share. It added that the company will maintain elevated EBITDA in the coming years.
 CLSA on ONGC : The brokerage upgraded the stock to 'outperform' and raised the target to Rs 105 per share from Rs 90 earlier. It also raised FY21 EPS for the stock by 10-18 percent on stronger crude in Q4 and FY22-23.
CLSA on ONGC: The brokerage upgraded the stock to 'outperform' and raised the target to Rs 105 per share from Rs 90 earlier. It also raised FY21 EPS for the stock by 10-18 percent on stronger crude in Q4 and FY22-23.
 CLSA on Info Edge:  The brokerage maintains 'outperform' call on the stock and raised its target to Rs 5,740 per share from Rs 3,580 earlier. It raised the target to factor in an improved long-term growth outlook.
CLSA on Info Edge: The brokerage maintains 'outperform' call on the stock and raised its target to Rs 5,740 per share from Rs 3,580 earlier. It raised the target to factor in an improved long-term growth outlook.
Published : February 16, 2021 08:51 AM IST
Live TV

recommended for you

Ask Our Experts CNBC TV18

Advertisement